{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:38:54Z","timestamp":1794494334316,"version":"4.9.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1K22CA270075-01"],"award-info":[{"award-number":["1K22CA270075-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.urolonc.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:05:08Z","timestamp":1723032308000},"page":"254-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Understanding the microbiome as a mediator of bladder cancer progression and therapeutic response"],"prefix":"10.1016","volume":"43","author":[{"given":"Mahgol","family":"Golshani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Woolbright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.07.004_bib0001","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskjot","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0002","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0003","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1200\/JCO.22.01643","article-title":"Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer","volume":"41","author":"Hoimes","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41585-022-00611-3","article-title":"Bladder cancer, inflammageing and microbiomes","volume":"19","author":"Martin","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0006","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1040270","article-title":"Pattern recognition receptor signaling and innate immune responses to schistosome infection","volume":"12","author":"Dibo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0008","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0010","first-page":"1","article-title":"Biological agents","volume":"100","author":"G.o.t.E.o.C.R.t Humans","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0011","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0012","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0013","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0016","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11912-024-01508-7","article-title":"Current trends and challenges of microbiome research in bladder cancer","volume":"26","author":"Isali","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0017","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2018.12.043","article-title":"The microbiome and genitourinary cancer: a collaborative review","volume":"75","author":"Markowski","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0018","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/BLC-200277","article-title":"The urinary microbiome and bladder cancer: susceptibility and immune responsiveness","volume":"6","author":"Andolfi","year":"2020","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0019","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.eururo.2021.05.018","article-title":"Is there a detrimental effect of antibiotic therapy in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab?","volume":"80","author":"Pederzoli","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","author":"Hilt","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0021","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0022-5347(01)68237-5","article-title":"Detection of eubacteria in interstitial cystitis by 16S rDNA amplification","volume":"158","author":"Heritz","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0022","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","article-title":"Temporal development of the gut microbiome in early childhood from the TEDDY study","volume":"562","author":"Stewart","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00327-17","article-title":"The gut microbiota of healthy aged Chinese is similar to that of the healthy young","volume":"2","author":"Bian","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0024","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41575-022-00605-x","article-title":"The gut microbiome as a modulator of healthy ageing","volume":"19","author":"Ghosh","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0026","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0027","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0028","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0029","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/s41418-021-00753-8","article-title":"Multifaceted modes of action of the anticancer probiotic enterococcus hirae","volume":"28","author":"Goubet","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2017.03.002","article-title":"Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction","volume":"21","author":"Thevaranjan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0031","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1038\/s41388-020-01509-3","article-title":"Emerging role of bacterial extracellular vesicles in cancer","volume":"39","author":"Chronopoulos","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0032","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.3748\/wjg.15.5549","article-title":"Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines","volume":"15","author":"Cox","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0033","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0034","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","article-title":"Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8(+) T cells","volume":"51","author":"Bachem","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0036","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0037","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal microbiota promote lung cancer development via gammadelta T Cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0038","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0039","first-page":"6362","article-title":"Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice","volume":"62","author":"Engle","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0040","article-title":"Spontaneous and induced tumors in germ-free animals: a general review","volume":"57","author":"Mishra","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0041","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1158\/0008-5472.CAN-13-0827","article-title":"Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury","volume":"73","author":"Zhan","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0042","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41388-017-0099-6","article-title":"A carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer","volume":"37","author":"Fantini","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0043","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc3858","article-title":"Modelling bladder cancer in mice: opportunities and challenges","volume":"15","author":"Kobayashi","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0044","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","article-title":"Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment","volume":"184","author":"Lam","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0045","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0046","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0047","doi-asserted-by":"crossref","first-page":"eabo2296","DOI":"10.1126\/science.abo2296","article-title":"A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers","volume":"380","author":"Fidelle","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.570077","article-title":"Association between antibiotic treatment and the efficacy of intravesical BCG therapy in patients with high-risk non-muscle invasive bladder cancer","volume":"11","author":"Pak","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0049","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/s41591-022-01965-2","article-title":"Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome","volume":"28","author":"Simpson","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0050","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0051","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0052","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0053","doi-asserted-by":"crossref","first-page":"22.e13","DOI":"10.1016\/j.urolonc.2023.11.003","article-title":"The bladder microbiota is not significantly altered by intravesical BCG therapy","volume":"42","author":"Heidrich","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0054","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.nutr.22.011602.092259","article-title":"How host-microbial interactions shape the nutrient environment of the mammalian intestine","volume":"22","author":"Hooper","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0056","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1096\/fj.201902626R","article-title":"Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p\/Bmi-1 axis in human bladder cancer cells","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0057","doi-asserted-by":"crossref","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485S","article-title":"Inhibition of histone deacetylase activity by butyrate","volume":"133","author":"Davie","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0058","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0059","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/JP272613","article-title":"Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study","volume":"595","author":"Boets","year":"2017","journal-title":"J Physiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0061","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0009-8981(70)90004-5","article-title":"Volatile fatty acids in normal human physiological fluids","volume":"29","author":"Perry","year":"1970","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0062","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-020-67443-2","article-title":"Bladder cancer-related microbiota: examining differences in urine and tissue samples","volume":"10","author":"Mansour","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0063","first-page":"395","article-title":"Gut microbial composition changes in bladder cancer patients: a case-control study in Harbin, China","volume":"29","author":"He","year":"2020","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0064","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnut.2019.00024","article-title":"Dietary and gut microbiota polyamines in obesity- and age-related diseases","volume":"6","author":"Ramos-Molina","year":"2019","journal-title":"Front Nutr"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0065","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2788","article-title":"Spermidine in health and disease","volume":"359","author":"Madeo","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0066","first-page":"3030","article-title":"TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma","volume":"5","author":"Madka","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0067","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00256832","article-title":"The diagnostic and prognostic value of urinary polyamine measurement in bladder cancer","volume":"9","author":"Pastorini","year":"1981","journal-title":"Urol Res"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0068","first-page":"5249","article-title":"Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis","volume":"49","author":"Uchida","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0069","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/srep00233","article-title":"Impact of intestinal microbiota on intestinal luminal metabolome","volume":"2","author":"Matsumoto","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3945\/ajcn.110.002188","article-title":"High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health","volume":"93","author":"Russell","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0071","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.ASN.0000039608.81046.81","article-title":"Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand","volume":"14","author":"Stewart","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0072","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat Rev Micro"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0073","article-title":"Shedding light on the cell biology of platelet-derived extracellular vesicles and their biomedical applications","volume":"13","author":"Chaudhary","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0074","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41596-019-0236-5","article-title":"Analyzing bacterial extracellular vesicles in human body fluids by orthogonal biophysical separation and biochemical characterization","volume":"15","author":"Tulkens","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41467-017-00729-8","article-title":"Bacterial outer membrane vesicles suppress tumor by interferon-gamma-mediated antitumor response","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0076","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.2147\/IJN.S304515","article-title":"Extracellular vesicles from akkermansia muciniphila elicit antitumor immunity against prostate cancer via modulation of CD8(+) T cells and macrophages","volume":"16","author":"Luo","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0077","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/gutjnl-2022-327853","article-title":"Acetyltransferase from Akkermansia muciniphila blunts colorectal tumourigenesis by reprogramming tumour microenvironment","volume":"72","author":"Jiang","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0078","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10238-022-00794-4","article-title":"Mycobacterium bovis bacille Calmette-Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy","volume":"23","author":"Gellings","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0079","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00262-022-03213-5","article-title":"Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients","volume":"71","author":"Jingushi","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12088-021-00991-x","article-title":"Dysbiosis of the human urinary microbiome and its association to diseases affecting the urinary system","volume":"62","author":"Jayalath","year":"2022","journal-title":"Indian J Microbiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2013.00041","article-title":"The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults","volume":"3","author":"Lewis","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0082","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5213\/inj.1938244.122","article-title":"The urine microbiome of healthy men and women differs by urine collection method","volume":"24","author":"Pohl","year":"2020","journal-title":"International Neurourology Journal"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0083","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","article-title":"Sex-specific alterations in the urinary and tissue microbiome in therapy-naive urothelial bladder cancer patients","volume":"3","author":"Pederzoli","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0084","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1479-5876-10-174","article-title":"Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury","volume":"10","author":"Fouts","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81790-8","article-title":"Pre-and postmenopausal women have different core urinary microbiota","volume":"11","author":"Ammitzb\u00f8ll","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0086","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.euo.2023.02.004","article-title":"Global meta-analysis of urine microbiome: colonization of polycyclic aromatic hydrocarbon\u2013degrading bacteria among bladder cancer patients","volume":"6","author":"Bukavina","year":"2023","journal-title":"European Urology Oncology"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0087","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1182322","article-title":"The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M","volume":"13","author":"Sun","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0088","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.euros.2023.11.003","article-title":"Microbiome profiling in bladder cancer patients using the first-morning urine sample","volume":"59","author":"Nardelli","year":"2024","journal-title":"European Urology Open Science"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0089","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.urolonc.2022.09.018","article-title":"Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition","volume":"41","author":"Hrb\u00e1\u010dek","year":"2023","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0090","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0091","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1038\/s41598-022-11819-z","article-title":"Characterizing the mucin-degrading capacity of the human gut microbiota","volume":"12","author":"Glover","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0092","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/carcin\/15.4.619","article-title":"Nitrate, nitrite and volatile N-nitroso compounds in the urine of schistosoma haematobium and schistosoma mansoni infected patients","volume":"15","author":"Mostafa","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0093","first-page":"1","article-title":"The microbiome in urogenital schistosomiasis and induced bladder pathologies","volume":"11","author":"Adebayo","year":"2017","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0094","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/oxfordjournals.aje.a113768","article-title":"Urinary tract infection and risk of bladder cancer","volume":"119","author":"Kantor","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0095","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/ijc.32842","article-title":"Urinary tract infections and risk of squamous cell carcinoma bladder cancer: a Danish nationwide case-control study","volume":"146","author":"Pottegard","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1125809","article-title":"Impact of intravesical bacillus Calmette-Gu\u00e9rin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer","volume":"13","author":"James","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0097","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12866-021-02407-8","article-title":"Urogenital microbiota:potentially important determinant of PD-L1 expression in male patients with non-muscle invasive bladder cancer","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0098","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000518090","article-title":"Use of antibiotics during immune checkpoint inhibitor treatment is associated with lower survival in hepatocellular carcinoma","volume":"10","author":"Cheung","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0099","doi-asserted-by":"crossref","first-page":"834.e821","DOI":"10.1016\/j.urolonc.2021.05.033","article-title":"Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma","volume":"39","author":"Ishiyama","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0100","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2017.08.022","article-title":"Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice","volume":"153","author":"Wong","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0101","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","article-title":"Gut microbiota in colorectal cancer: mechanisms of action and clinical applications","volume":"16","author":"Wong","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0102","first-page":"1","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"18","author":"Vincenzo","year":"2023","journal-title":"Internal and emergency medicine"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0103","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11383-3","article-title":"Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study","volume":"23","author":"Mingdong","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0104","doi-asserted-by":"crossref","DOI":"10.3390\/genes13111967","article-title":"Integrated analysis of the fecal metagenome and metabolome in bladder cancer in a chinese population","volume":"13","author":"Qin","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.eururo.2023.12.014","article-title":"Stool microbiome signature associated with response to neoadjuvant pembrolizumab in patients with muscle-invasive bladder cancer","volume":"85","author":"Pederzoli","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0106","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/ijc.31959","article-title":"Fermented dairy foods intake and risk of cancer","volume":"144","author":"Zheng","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2024.07.004_bib0107","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/cas.15666","article-title":"Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer","volume":"114","author":"Miyake","year":"2023","journal-title":"Cancer Sci"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T03:42:47Z","timestamp":1741664567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924005416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1078143924005416"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.07.004","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the microbiome as a mediator of bladder cancer progression and therapeutic response","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}